Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The regulation of PBXs and their emerging role in cancer
Ying Liu, Xiang Ao, Xuehao Zhou, et al.
Journal of Cellular and Molecular Medicine (2022) Vol. 26, Iss. 5, pp. 1363-1379
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy
Guido Ghilardi, Joseph A. Fraietta, James N. Gerson, et al.
Nature Medicine (2024)
Closed Access | Times Cited: 122
Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications
Xuehao Zhou, Xiang Ao, Zhaojun Jia, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 79
Non-coding RNAs regulating mitochondrial function in cardiovascular diseases
Xiang Ao, Wei Ding, Xiaoge Li, et al.
Journal of Molecular Medicine (2023) Vol. 101, Iss. 5, pp. 501-526
Closed Access | Times Cited: 50
Non-coding RNA-mediated modulation of ferroptosis in cardiovascular diseases
Ying Liu, Wei Ding, Jianxun Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114993-114993
Open Access | Times Cited: 50
Non-coding RNAs in lung cancer: molecular mechanisms and clinical applications
Ying Liu, Wei‐Qun Ding, Jianxun Wang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 42
FOXO3a in cancer drug resistance
Ying Liu, Yu Wang, Xiaoge Li, et al.
Cancer Letters (2022) Vol. 540, pp. 215724-215724
Closed Access | Times Cited: 54
The Interaction of Polyphenols and the Gut Microbiota in Neurodegenerative Diseases
Yuan Zhang, Wanpeng Yu, Lei Zhang, et al.
Nutrients (2022) Vol. 14, Iss. 24, pp. 5373-5373
Open Access | Times Cited: 47
Increasing the Throughput and Reproducibility of Activity-Based Proteome Profiling Studies with Hyperplexing and Intelligent Data Acquisition
Hanna G. Budayeva, P. Taylur, Shuai Wang, et al.
Journal of Proteome Research (2024) Vol. 23, Iss. 8, pp. 2934-2947
Open Access | Times Cited: 9
PBX1 as a novel master regulator in cancer: Its regulation, molecular biology, and therapeutic applications
Ting‐Wan Kao, Hsiao-Han Chen, James C. Lin, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 2, pp. 189085-189085
Open Access | Times Cited: 8
Exosomal noncoding RNAs in central nervous system diseases: biological functions and potential clinical applications
Zhongyu Wang, Zeng-Jin Wen, Hai-Ming Xu, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 35
The FOXO family of transcription factors: key molecular players in gastric cancer
Ying Liu, Xiang Ao, Yi Jia, et al.
Journal of Molecular Medicine (2022) Vol. 100, Iss. 7, pp. 997-1015
Closed Access | Times Cited: 33
Single-cell RNA-sequencing and genome-wide Mendelian randomisation along with abundant machine learning methods identify a novel B cells signature in gastric cancer
Qi Ma, Jie Gao, Yuan Hui, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
A Genome- and Phenome-Wide Association Study of Serum Procalcitonin Concentrations in Individuals of European Ancestry
Wenbo Zhang, Peter J. van der Most, Siqi Wang, et al.
(2025)
Closed Access
FADD as a key molecular player in cancer progression
Ying Liu, Xiaoge Li, Xuehao Zhou, et al.
Molecular Medicine (2022) Vol. 28, Iss. 1
Open Access | Times Cited: 26
Role and regulation of FOXO3a: new insights into breast cancer therapy
Wenqiu Mei, Bingyin Mei, Jing Chang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Underlying mechanisms of epithelial splicing regulatory proteins in cancer progression
Ying Liu, Yiwen Li, Chengcheng Du, et al.
Journal of Molecular Medicine (2022) Vol. 100, Iss. 11, pp. 1539-1556
Closed Access | Times Cited: 21
The crosstalk between the gut microbiota and tumor immunity: Implications for cancer progression and treatment outcomes
Man Wang, Lei Zhang, Wenguang Chang, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 11
Unique regulatory roles of ncRNAs changed by PM2.5 in human diseases
Bo He, Hai-Ming Xu, Haowen Liu, et al.
Ecotoxicology and Environmental Safety (2023) Vol. 255, pp. 114812-114812
Open Access | Times Cited: 10
Interplay between Gut Microbiota and NLRP3 Inflammasome in Intracerebral Hemorrhage
Yuan Zhang, Wanpeng Yu, Christopher Flynn, et al.
Nutrients (2022) Vol. 14, Iss. 24, pp. 5251-5251
Open Access | Times Cited: 17
Noncoding RNA-mediated regulation of pyroptotic cell death in cancer
Man Wang, Yuan Zhang, Wenguang Chang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 16
Pro-inflammatory polarization and colorectal cancer modulate alternative and intronic polyadenylation in primary human macrophages
Joana Wilton, Filipa Lopes de Mendonça, Isabel Pereira‐Castro, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Noncoding RNAs as an emerging resistance mechanism to immunotherapies in cancer: basic evidence and therapeutic implications
Man Wang, Fei Yu, Peifeng Li
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Increasing the Throughput and Reproducibility of Activity-Based Proteome Profiling Studies with Hyperplexing and Intelligent Data Acquisition
Hanna G. Budayeva, P. Taylur, Shuai Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Asian-European differentiation of schizophrenia-associated genes driven by admixture and natural selection
Sihan Chen, Dié Tang, Lian Deng, et al.
iScience (2024) Vol. 27, Iss. 5, pp. 109560-109560
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top